Renal replacement therapy (18.26, 1.0E-4); acute renal failure (14.46, 0.001); serum albumin (10.98, 0.001); prognostic scores (10.98, 0.001); acute (10.98, 0.001). This evidence concerns the gene ALB and acute kidney injury.